INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 145 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $19,431,000 | -26.3% | 375,399 | +3.5% | 0.07% | -1.4% |
| Q1 2022 | $26,361,000 | -76.5% | 362,750 | -61.7% | 0.07% | -72.5% |
| Q4 2021 | $111,954,000 | -20.6% | 946,834 | -9.9% | 0.26% | -24.3% |
| Q3 2021 | $140,965,000 | -2.3% | 1,050,799 | +17.9% | 0.34% | -3.2% |
| Q2 2021 | $144,245,000 | +164.7% | 890,900 | +31.2% | 0.35% | +150.4% |
| Q1 2021 | $54,504,000 | +1438.4% | 679,141 | +155.9% | 0.14% | +1058.3% |
| Q3 2019 | $3,543,000 | -23.6% | 265,382 | -6.3% | 0.01% | -20.0% |
| Q2 2019 | $4,638,000 | -24.4% | 283,286 | -21.1% | 0.02% | -25.0% |
| Q1 2019 | $6,133,000 | +79.5% | 359,028 | +43.5% | 0.02% | +66.7% |
| Q4 2018 | $3,416,000 | -27.7% | 250,203 | +51.6% | 0.01% | -7.7% |
| Q3 2018 | $4,725,000 | – | 165,079 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 752,024 | $100,884,000 | 18.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 420,859 | $56,458,000 | 4.40% |
| Discovery Value Fund | 922,411 | $123,741,000 | 3.63% |
| MPM BioImpact LLC | 162,620 | $21,815,000 | 3.38% |
| Ally Bridge Group (NY) LLC | 65,000 | $8,720,000 | 2.56% |
| ARK Investment Management | 6,743,556 | $904,648,000 | 2.17% |
| Integral Health Asset Management, LLC | 50,000 | $6,708,000 | 1.93% |
| Yorktown Management & Research Co Inc | 18,300 | $2,455,000 | 1.85% |
| Interchange Capital Partners, LLC | 8,191 | $1,098,000 | 1.84% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $14,950,000 | 1.76% |